AQQRF Stock Chart & Stats
$0.50
$0.00(0.00%)
At close: 4:00 PM EST
$0.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $1.00
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$294.73K
Enterprise Value$7.30M
Total Cash (Recent Filing)$47.66K
Total Debt (Recent Filing)$7.07M
Price to Earnings (P/E)―
Beta-169.08
Next Earnings
Dec 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding27,599,173
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.06
Price to Sales (P/S)4.53
P/FCF Ratio-3.56
Enterprise Value/Market Cap24.78
Enterprise Value/Revenue79.71
Enterprise Value/Gross Profit182.44
Enterprise Value/Ebitda-34.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe 20.3% TTM revenue rebound provides evidence of renewed demand for the company’s surgical technologies and related solutions. If maintained, improving sales can broaden operating scale, support customer adoption, and create a stronger base for eventual cost absorption.
Industry-Level Gross MarginA TTM gross margin of about 44% indicates that the company’s products generate meaningful value above direct costs. This provides a potential foundation for future operating leverage, although sustained profitability still depends on controlling operating expenses and other costs.
Reduced Cash BurnTTM free cash flow remains negative, but the smaller cash burn versus 2025 suggests some improvement in cash consumption. If this direction persists, it could extend financial runway and reduce the pace at which external funding is needed to sustain operations.
Bears Say
Persistent UnprofitabilityThe extremely negative TTM net margin, together with ongoing EBIT and EBITDA losses, shows that revenue and gross profit are not covering the company’s operating and non-operating cost base. Persistent losses weaken internal funding capacity and make a durable earnings recovery uncertain.
Stressed Capital StructureNegative equity and debt that materially exceeds the asset base indicate limited balance-sheet resilience. This structure can constrain investment and strategic flexibility while increasing refinancing and potential dilution risk, making the company more vulnerable if losses continue.
Ongoing External Funding DependenceNegative operating and free cash flow show that the business is not yet funding operations from internally generated cash. Continued cash burn can reduce financial flexibility and require additional external funding, especially while profitability and the balance sheet remain weak.
AQQRF FAQ
What was Aquarius Surgical Technologies Inc.’s price range in the past 12 months?
Aquarius Surgical Technologies Inc. lowest stock price was <$0.01 and its highest was $1.00 in the past 12 months.
What is Aquarius Surgical Technologies Inc.’s market cap?
Aquarius Surgical Technologies Inc.’s market cap is $294.73K.
When is Aquarius Surgical Technologies Inc.’s upcoming earnings report date?
Aquarius Surgical Technologies Inc.’s upcoming earnings report date is Dec 02, 2026 which is in 40 days.
How were Aquarius Surgical Technologies Inc.’s earnings last quarter?
Aquarius Surgical Technologies Inc. released its earnings results on Jul 27, 2026. The company reported -$0.004 earnings per share for the quarter.
Is Aquarius Surgical Technologies Inc. overvalued?
According to Wall Street analysts Aquarius Surgical Technologies Inc.’s price is currently Overvalued.
Does Aquarius Surgical Technologies Inc. pay dividends?
Aquarius Surgical Technologies Inc. does not currently pay dividends.
What is Aquarius Surgical Technologies Inc.’s EPS estimate?
Aquarius Surgical Technologies Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aquarius Surgical Technologies Inc. have?
Aquarius Surgical Technologies Inc. has 27,599,173 shares outstanding.
What happened to Aquarius Surgical Technologies Inc.’s price movement after its last earnings report?
Aquarius Surgical Technologies Inc. reported an EPS of -$0.004 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aquarius Surgical Technologies Inc.?
Currently, no hedge funds are holding shares in AQQRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aquarius Surgical Technologies Inc.
Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings throughout Canada and the United States. The company's core offering comprises sophisticated medical laser systems, catering to a diverse array of specialties such as urology, gynecology, ophthalmology, thoracic surgery, otolaryngology (ENT), cardiovascular procedures, and neurosurgery. Incorporated in 1986, the Toronto, Canada-based firm was previously known as Aquarius Coatings Inc.
Technical Analysis
Aurora Spine
―
―
Perimeter Medical Imaging AI
―
Profound Medical
―
VentriPoint Diagnostics
―